Keywords: congress, report, off-label, promotion, there, often, line

US CONGRESS REPORT ON OFF-LABEL PROMOTION

Article | 07 December 1992

Print This

There is often "a fine line" between the sharing of research results and the promotion of a drug, according to ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in